Operator: Greetings, and welcome to the Edwards Lifesciences Corporation Third Quarter 2010 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, David Erickson, Vice President, Investor Relations for Edwards Lifesciences Corporation. Thank you. Mr. Erickson, you may begin.
David K. Erickson - VP, IR: Welcome, and thank you for joining us today. Just after the close of regular trading, we released our third quarter 2010 financial results. However, we've been made aware that our 8-K filing was unintentionally made public just minutes before the close of the market and in advance of our press release. We are disappointed this occurred and are currently researching the cause. During today's call, we'll discuss the results included in the press release and accompanying financial schedules, and then use the remaining time for Q&A.
Our presenters on today's call are Mike Mussallem, Chairman and CEO; and Tom Abate, CFO and Treasurer.
Before I turn the call over to Mike, I'd like to remind you that during today's call we will be making forward-looking statements that are based on estimates, assumptions, and projections. These statements include, but aren't limited to, our expectations regarding sales and sales growth, gross profit margin, net income and net income growth, goals for earnings per share and earnings growth and free cash flow and other financial expectations for 2010. The sales of Heart Valve Therapy products including Magna Ease, Magna Mitral Ease, and Physio II; clinical study of Project Odyssey, the continued adoption and expected 2010 sales of the SAPIEN and SAPIEN XT valves; the timing and results of transcatheter valve clinical studies including the PARTNER and PARTNER II trials, the development of continuous blood glucose monitoring technology, and the impact of foreign exchange fluctuations and special items on our financial results.
These statements speak only as of the date on which they are made and we do not undertake any obligation to update them after today. Although we believe them to be reasonable, these statements involve risks and uncertainties that could cause actual results or experiences to differ materially from the forward-looking statements.
Information concerning factors that could cause these differences may be found in our press release, our Annual Report on Form 10-K for the year ended December 31, 2009, and our other SEC filings, which are all available on our website at edwards.com.
With that, I'll turn the call over to Mike Mussallem. Mike?
Michael A. Mussallem - Chairman and CEO: Thank you, David. We're very pleased to report solid third quarter results, continued demand for our innovative new products again drove double digit underlying sales growth. This combined with the more favorable foreign exchange environment gives us confidence to raise our earnings outlook for the year even during this difficult economic climate.